| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1007/S00018-010-0579-0 |
| P698 | PubMed publication ID | 21116680 |
| P50 | author | Edgardo D. Carosella | Q3047538 |
| Nathalie Rouas-Freiss | Q87819345 | ||
| Catherine Menier | Q123425586 | ||
| Joel LeMaoult | Q56285708 | ||
| Silvia Gregori | Q38642221 | ||
| P2093 | author name string | Benoit Favier | |
| P2860 | cites work | A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells | Q24310017 |
| Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway | Q24310325 | ||
| Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6--STAT3 signaling pathway | Q24321398 | ||
| Disulfide bond-mediated dimerization of HLA-G on the cell surface. | Q24541505 | ||
| The human natural killer cell immune synapse | Q24656137 | ||
| A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells | Q24676716 | ||
| Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G | Q24678795 | ||
| High molecular response rate of polycythemia vera patients treated with pegylated interferon alpha-2a | Q27824871 | ||
| HLA-G molecules: from maternal-fetal tolerance to tissue acceptance | Q28237673 | ||
| A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera | Q28241887 | ||
| Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules | Q28266749 | ||
| HLA-G: from biology to clinical benefits | Q28267372 | ||
| Beyond the increasing complexity of the immunomodulatory HLA-G molecule | Q28272361 | ||
| HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells | Q28304268 | ||
| Mesenchymal stem cells in health and disease | Q29614296 | ||
| Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis | Q29614337 | ||
| Regulatory T cells and immune tolerance | Q29616864 | ||
| A gain-of-function mutation of JAK2 in myeloproliferative disorders | Q29618851 | ||
| Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders | Q29618853 | ||
| A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis | Q29619339 | ||
| Intercellular transfer and supramolecular organization of human leukocyte antigen C at inhibitory natural killer cell immune synapses | Q30764788 | ||
| Ig-like transcript 2 (ILT2)/leukocyte Ig-like receptor 1 (LIR1) inhibits TCR signaling and actin cytoskeleton reorganization. | Q31839097 | ||
| Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer | Q33181504 | ||
| Recruitment of activation receptors at inhibitory NK cell immune synapses | Q33372126 | ||
| HLA-G: a tolerance molecule from the major histocompatibility complex | Q33546847 | ||
| HLA-G expression during preimplantation human embryo development | Q33605771 | ||
| The mature activating natural killer cell immunologic synapse is formed in distinct stages | Q33715602 | ||
| HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells | Q33782535 | ||
| Haematopoietic stem cells derive directly from aortic endothelium during development | Q33805589 | ||
| Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface | Q33927547 | ||
| Epithelial damage and response | Q33940581 | ||
| HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis | Q33941618 | ||
| Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection | Q33958986 | ||
| Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis. | Q33980323 | ||
| Tolerization of dendritic cells by HLA-G. | Q33985802 | ||
| HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism? | Q33991445 | ||
| Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells | Q33993682 | ||
| Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells | Q34000613 | ||
| CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance. | Q34006562 | ||
| Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses. | Q34007049 | ||
| Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. | Q34007524 | ||
| Non-classical transcriptional regulation of HLA-G: an update | Q34017943 | ||
| Immunohistochemical study of HLA-G expression in lung transplant recipients | Q34018814 | ||
| ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse | Q34019822 | ||
| Different functional outcomes of intercellular membrane transfers to monocytes and T cells. | Q34021678 | ||
| An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes | Q34060754 | ||
| Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis | Q34065286 | ||
| A common precursor for hematopoietic and endothelial cells. | Q34452940 | ||
| Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. | Q34569888 | ||
| Exchanges of membrane patches (trogocytosis) split theoretical and actual functions of immune cells. | Q34578243 | ||
| Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells | Q34609504 | ||
| Role of regulatory T cells and FOXP3 in human diseases. | Q34657962 | ||
| Update on clinical role of tamoxifen | Q35051988 | ||
| Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d) | Q35133849 | ||
| HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? | Q35746565 | ||
| High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. | Q36362685 | ||
| Functional dichotomy in natural killer cell signaling: Vav1-dependent and -independent mechanisms | Q36368907 | ||
| Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response | Q36732268 | ||
| Research on HLA-G: an update. | Q36817290 | ||
| Differently phosphorylated forms of the cortactin homolog HS1 mediate distinct functions in natural killer cells | Q37055018 | ||
| Is FOXP3 a bona fide marker for human regulatory T cells? | Q37131913 | ||
| A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. | Q37235176 | ||
| Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells | Q60273498 | ||
| Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy | Q62513537 | ||
| Leukemia inhibitory factor (LIF) stimulates the human HLA-G promoter in JEG3 choriocarcinoma cells | Q73148534 | ||
| Interleukin-10 induces the upregulation of the inhibitory receptor ILT4 in monocytes from HIV positive individuals | Q73261036 | ||
| Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice | Q73550089 | ||
| Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation | Q73937145 | ||
| Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G | Q74179358 | ||
| Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma | Q74236905 | ||
| Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis | Q75210985 | ||
| Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer | Q77667246 | ||
| IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes | Q77756347 | ||
| Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself | Q78231300 | ||
| HLA-G inhibits the allogeneic proliferative response | Q78231323 | ||
| sHLA-G levels in the monitoring of immunosuppressive therapy and rejection following heart transplantation | Q79421006 | ||
| Mechanisms of prolongation of allograft survival by HLA-G/ILT4-modified dendritic cells | Q80073821 | ||
| Synthesis of beta(2)-microglobulin-free, disulphide-linked HLA-G5 homodimers in human placental villous cytotrophoblast cells | Q80278200 | ||
| Soluble human leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graft-versus-host disease and a link with regulatory T cells | Q80609656 | ||
| Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients | Q81170092 | ||
| Myeloproliferative disorders | Q81943280 | ||
| Human leukocyte antigen-G is expressed in advanced-stage ovarian carcinoma of high-grade histology | Q84362989 | ||
| Isoforms of human leukocyte antigen-G and their inhibitory receptors in human kidney allograft acceptance | Q84372228 | ||
| Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype | Q40614057 | ||
| Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules. | Q40670122 | ||
| HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor | Q40705349 | ||
| MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal | Q40718577 | ||
| A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape | Q40736274 | ||
| Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule | Q40752143 | ||
| B cells acquire antigen from target cells after synapse formation | Q40803432 | ||
| HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition | Q40831269 | ||
| HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival | Q40834758 | ||
| TCR-Mediated internalization of peptide-MHC complexes acquired by T cells | Q40920256 | ||
| Antigen presentation by T cells: T cell receptor ligation promotes antigen acquisition from professional antigen-presenting cells. | Q41065321 | ||
| A class I antigen, HLA-G, expressed in human trophoblasts | Q41737375 | ||
| Identification and characterization of IL-10/IFN-gamma-producing effector-like T cells with regulatory function in human blood | Q42572213 | ||
| Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. | Q42640095 | ||
| Soluble HLA-G molecule. An alternatively spliced HLA-G mRNA form candidate to encode it in peripheral blood mononuclear cells and human trophoblasts | Q42676487 | ||
| Cutting edge: CTLs rapidly capture membrane fragments from target cells in a TCR signaling-dependent manner | Q42831375 | ||
| HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro | Q43201587 | ||
| Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg | Q43277215 | ||
| Increased expression of regulatory Tr1 cells in recurrent hepatitis C after liver transplantation | Q43534965 | ||
| Erythroblasts are a source of angiogenic factors | Q43550995 | ||
| Spatial organization of signal transduction molecules in the NK cell immune synapses during MHC class I-regulated noncytolytic and cytolytic interactions. | Q43760121 | ||
| Synaptic transfer by human gamma delta T cells stimulated with soluble or cellular antigens | Q44021522 | ||
| HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes | Q44062284 | ||
| Acquisition of CD80 by human T cells at early stages of activation: functional involvement of CD80 acquisition in T cell to T cell interaction | Q44223884 | ||
| Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function | Q44521264 | ||
| High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells | Q44580638 | ||
| Mobilizing dendritic cells for tolerance by engagement of immune inhibitory receptors for HLA-G. | Q44645237 | ||
| Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells | Q44967317 | ||
| A novel pathway of alloantigen presentation by dendritic cells | Q45094759 | ||
| The Tregs' world according to GARP. | Q45854995 | ||
| Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines | Q45889051 | ||
| Tryptophan deprivation induces inhibitory receptors ILT3 and ILT4 on dendritic cells favoring the induction of human CD4+CD25+ Foxp3+ T regulatory cells. | Q45964911 | ||
| HLA-G expression is up-regulated by progesterone in mesenchymal stem cells. | Q45968795 | ||
| Rapamycin downregulates the inhibitory receptors ILT2, ILT3, ILT4 on human dendritic cells and yet induces T cell hyporesponsiveness independent of FoxP3 induction | Q46464187 | ||
| Transfer of antigen from macrophages to lymphocytes. II. Immunological significance of the transfer of lipopolysaccharide | Q46667603 | ||
| Progesterone enhances HLA-G gene expression in JEG-3 choriocarcinoma cells and human cytotrophoblasts in vitro | Q46740011 | ||
| Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. | Q46925575 | ||
| p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily. | Q47915809 | ||
| T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells is IL-10-dependent and reversible | Q47921476 | ||
| Embryonic human leukocyte antigen-G expression: possible implications for human preimplantation development. | Q48064664 | ||
| HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation. | Q48235309 | ||
| Production of sHLA-G molecules by in vitro matured cumulus-oocyte complex | Q48714170 | ||
| Differential expression of alternatively spliced transcripts of HLA-G in human preimplantation embryos and inner cell masses. | Q50654657 | ||
| Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004. | Q52661569 | ||
| Blood stem cells emerge from aortic endothelium by a novel type of cell transition. | Q53341991 | ||
| Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders. | Q53544486 | ||
| Dendritic cells secrete the immunosuppressive HLA-G molecule upon CTLA4-Ig treatment: implication in human renal transplant acceptance. | Q54454439 | ||
| Implication of HLA-G molecule in heart-graft acceptance. | Q55034070 | ||
| A Specific Interferon (IFN)-stimulated Response Element of the Distal HLA-G Promoter Binds IFN-regulatory Factor 1 and Mediates Enhancement of This Nonclassical Class I Gene by IFN-β | Q57251046 | ||
| Vav1 Controls DAP10-Mediated Natural Cytotoxicity by Regulating Actin and Microtubule Dynamics | Q57275873 | ||
| HLA-G Expression in Atopic Dermatitis | Q57913984 | ||
| Foxp3-dependent programme of regulatory T-cell differentiation | Q59084714 | ||
| HLA-G-dependent suppressor cells: Diverse by nature, function, and significance. | Q37279472 | ||
| Formation and function of the lytic NK-cell immunological synapse | Q37378585 | ||
| Induction of ILT expression on nonprofessional antigen presenting cells: Clinical applications | Q37465092 | ||
| Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells. | Q37576202 | ||
| Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens | Q37599451 | ||
| Blood cell generation from the hemangioblast. | Q37621329 | ||
| Progesterone in pregnancy; receptor-ligand interaction and signaling pathways | Q37625479 | ||
| Recent advances on the non-classical major histocompatibility complex class I HLA-G molecule | Q37667161 | ||
| In vivo imaging of haematopoietic cells emerging from the mouse aortic endothelium | Q37692173 | ||
| Human and murine inhibitory natural killer cell receptors transfer from natural killer cells to target cells | Q37695578 | ||
| Extracellular ATP acting at the P2X7 receptor inhibits secretion of soluble HLA-G from human monocytes. | Q39800283 | ||
| Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis | Q39808633 | ||
| Human melanoma cell secreting human leukocyte antigen-G5 inhibit natural killer cell cytotoxicity by impairing lytic granules polarization toward target cell | Q39816917 | ||
| Niflumic acid renders dendritic cells tolerogenic and up-regulates inhibitory molecules ILT3 and ILT4. | Q39846816 | ||
| Progesterone induces human leukocyte antigen-g expression in vascular endothelial and smooth muscle cells | Q40038095 | ||
| HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F dephosphorylation: clinical relevance in polycythemia vera. | Q40039592 | ||
| HLA-G expression is induced in Epstein-Barr virus-transformed B-cell lines by culture conditions | Q40131704 | ||
| Hypoxia modulates HLA-G gene expression in tumor cells. | Q40151387 | ||
| Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/ILT-4/FasL-mediated pathways | Q40151394 | ||
| HLA-G complexes are observed on the cell surface | Q40151398 | ||
| Trogocytosis-based generation of suppressive NK cells | Q40167565 | ||
| Segregation of HLA-C from ICAM-1 at NK cell immune synapses is controlled by its cell surface density | Q40212550 | ||
| Increase in HLA-G1 proteolytic shedding by tumor cells: a regulatory pathway controlled by NF-kappaB inducers. | Q40214384 | ||
| Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells | Q40313866 | ||
| Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes | Q40327449 | ||
| A novel sandwich ELISA for alpha1 domain based detection of soluble HLA-G heavy chains | Q40347074 | ||
| The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G molecules | Q40364736 | ||
| T cell activation correlates with an increased proportion of antigen among the materials acquired from target cells | Q40397409 | ||
| A new dynamic model of CD8+ T effector cell responses via CD4+ T helper-antigen-presenting cells | Q40412171 | ||
| Acquisition of HLA-DR and costimulatory molecules by T cells from allogeneic antigen presenting cells | Q40412313 | ||
| Heat shock and arsenite induce expression of the nonclassical class I histocompatibility HLA-G gene in tumor cell lines | Q40424879 | ||
| Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients | Q40584279 | ||
| P433 | issue | 3 | |
| P921 | main subject | hemopoiesis | Q919283 |
| P304 | page(s) | 353-368 | |
| P577 | publication date | 2010-11-30 | |
| P1433 | published in | Cellular and Molecular Life Sciences | Q5058352 |
| P1476 | title | The role of HLA-G in immunity and hematopoiesis | |
| P478 | volume | 68 |
| Q34714685 | A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients |
| Q37864697 | Clinical tolerance in allogeneic hematopoietic stem cell transplantation |
| Q42184849 | Evaluation of gene delivery strategies to efficiently overexpress functional HLA-G on human bone marrow stromal cells |
| Q37276476 | Exocytosis acts as a modulator of the ILT4-mediated inhibition of neutrophil functions |
| Q48337140 | Genetic diversity of the HLA-G coding region in Amerindian populations from the Brazilian Amazon: a possible role of natural selection. |
| Q45878428 | Genotypes and haplotypes in the 3' untranslated region of the HLA-G gene and their association with clinical outcome of hematopoietic stem cell transplantation for beta-thalassemia |
| Q36568297 | HLA-G expression in cancers: roles in immune evasion, metastasis and target for therapy |
| Q37704942 | HLA-G expression on blasts and tolerogenic cells in patients affected by acute myeloid leukemia |
| Q39432611 | HLA-G inhibition of NK-cell cytolytic function is uncoupled from tumor cell lipid raft reorganization |
| Q39334954 | HLA-G1 and HLA-G5 active dimers are present in malignant cells and effusions: the influence of the tumor microenvironment. |
| Q57490851 | Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges |
| Q39241549 | Human skin-derived precursor cells are poorly immunogenic and modulate the allogeneic immune response |
| Q26740300 | Immunoregulatory Role of HLA-G in Allergic Diseases |
| Q39588867 | Inhibition of human gamma delta [corrected] T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer |
| Q43462890 | MHC class I expression in HPV positive and negative tonsillar squamous cell carcinoma in correlation to clinical outcome |
| Q34206215 | MiRNA-mediated control of HLA-G expression and function |
| Q34075123 | Presence of antigen-experienced T cells with low grade of differentiation and proliferative potential in chronic Chagas disease myocarditis |
| Q36202227 | Progesterone and autoimmune disease |
| Q38377860 | Regulation of neutrophil functions through inhibitory receptors: an emerging paradigm in health and disease |
| Q33642419 | Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation |
| Q36271612 | Soluble human leukocyte antigen -G during pregnancy and infancy in Benin: Mother/child resemblance and association with the risk of malaria infection and low birth weight |
| Q36317668 | Structural insights into activation of antiviral NK cell responses |
| Q38963370 | The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy |
| Q47224028 | The Folate Cycle As a Cause of Natural Killer Cell Dysfunction and Viral Etiology in Type 1 Diabetes. |
| Q89769517 | Therapeutic Mesenchymal Stromal Cells for Immunotherapy and for Gene and Drug Delivery |
| Q26740125 | Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease |
Search more.